Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Computer Methods and Programs in Biomedicine|March 1, 1986
Critiquing the process of radiologic differential diagnosisP L Miller, C Shaw, J R Rose, et al.Infection and Immunity|March 1, 1995
Agonistic and antagonistic activities of bacterially derived Rhodobacter sphaeroides lipid A: comparison with activities of synthetic material of the proposed structure and analogsJ R Rose, W J Christ, J R Bristol, et al.Journal of Spinal Disorders|March 1, 1989
Anterior discectomy, microscopic decompression, and fusion: a treatment for cervical spondylotic radiculopathyJ A Kozak, G W Hanson, J R Rose, et al.Journal of Endotoxin Research|August 25, 2001
Examination of chlorpromazine and other amphipathic drugs on the activity of lipopolysaccharide antagonists, E5564 and E5531H Yang, J M Daun, J R Rose, et al.Journal of Virology|November 1, 1996
Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell linesU Junker, S Escaich, I Plavec, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|January 1, 1987
HYDRA: a knowledge acquisition tool for expert systems that critique medical workupP L Miller, S J Blumenfrucht, J R Rose, et al.Antimicrobial Agents and Chemotherapy|February 19, 2000
Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteinsJ R Rose, M A Mullarkey, W J Christ, et al.British Journal of Pharmacology|August 5, 1999
E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharideT Kawata, J R Bristol, D P Rossignol, et al.Progress in Clinical and Biological Research|January 1, 1995
Anti-endotoxin activity of a novel synthetic lipid A analogT Kawata, J R Bristol, J R Rose, et al.Pageof 1